Last reviewed · How we verify
Continuation of spironolactone — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Continuation of spironolactone (Continuation of spironolactone) — Asan Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Continuation of spironolactone TARGET | Continuation of spironolactone | Asan Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Continuation of spironolactone CI watch — RSS
- Continuation of spironolactone CI watch — Atom
- Continuation of spironolactone CI watch — JSON
- Continuation of spironolactone alone — RSS
Cite this brief
Drug Landscape (2026). Continuation of spironolactone — Competitive Intelligence Brief. https://druglandscape.com/ci/continuation-of-spironolactone. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab